US Stock MarketDetailed Quotes

BCRX BioCryst Pharmaceuticals

Watchlist
  • 7.570
  • +0.180+2.44%
Close Dec 20 16:00 ET
  • 7.630
  • +0.060+0.79%
Post 20:05 ET
1.57BMarket Cap-12.41P/E (TTM)

About BioCryst Pharmaceuticals Company

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Company Profile

SymbolBCRX
Company NameBioCryst Pharmaceuticals
Listing DateMar 3, 1994
Issue Price6.50
Founded1986
CEOMr. Jon P. Stonehouse
MarketNASDAQ
Employees536
Fiscal Year Ends12-31
Address4505 Emperor Boulevard,Suite 200
CityDurham
ProvinceNorth Carolina
CountryUnited States of America
Zip Code27703-8457
Phone1-919-859-1302
Websitehttp://www.biocryst.com

Company Executives

  • Name
  • Position
  • Salary
  • Jon P. Stonehouse
  • Director, President and Chief Executive Officer
  • 4.78M
  • Anthony Doyle
  • Chief Financial Officer, Treasurer and Interim Principal Accounting Officer
  • 1.79M
  • Charles K. Gayer
  • Chief Commercial Officer
  • 1.74M
  • Dr. Helen M. Thackray, M.D.
  • Chief Research and Development Officer
  • 2.39M
  • Alane Barnes
  • Chief Legal Officer and Corporate Secretary
  • 1.93M
  • Dr. Nancy J. Hutson, PhD
  • Chairman of the Board
  • 470.30K
  • Vincent J. Milano
  • Independent Director
  • 434.82K
  • Dr. Amy McKee
  • Independent Director
  • 422.32K
  • Stephen J. Aselage
  • Independent Director
  • 446.90K
  • Machelle Sanders
  • Independent Director
  • 423.15K
  • Theresa M. Heggie
  • Independent Director
  • 433.57K
  • Alan G. Levin
  • Independent Director
  • 434.54K
  • George B. Abercrombie
  • Independent Director
  • 432.74K
  • Dr. Steven Galson, M.D.
  • Independent Director
  • 424.40K
Heat List
US
Overall
Symbol
Price
% Chg

No Data